InfuSystem (INFU) Competitors

InfuSystem (NYSE:INFU) and Semler Scientific (NASDAQ:SMLR) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, media sentiment, dividends, risk, profitability and institutional ownership.

Which has higher earnings & valuation, INFU or SMLR?

Semler Scientific has lower revenue, but higher earnings than InfuSystem. Semler Scientific is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InfuSystem	$139.89M	1.29	$870K	$0.23	38.39
Semler Scientific	$56.29M	9.51	$40.90M	$2.43	14.87

Which has more volatility and risk, INFU or SMLR?

InfuSystem has a beta of 1.81, meaning that its share price is 81% more volatile than the S&P 500. Comparatively, Semler Scientific has a beta of 1.34, meaning that its share price is 34% more volatile than the S&P 500.

Does the media favor INFU or SMLR?

In the previous week, InfuSystem had 13 more articles in the media than Semler Scientific. MarketBeat recorded 25 mentions for InfuSystem and 12 mentions for Semler Scientific. InfuSystem's average media sentiment score of 0.58 beat Semler Scientific's score of 0.23 indicating that InfuSystem is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InfuSystem	4 Very Positive mention(s)	0 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Semler Scientific	0 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do institutionals & insiders hold more shares of INFU or SMLR?

71.1% of InfuSystem shares are owned by institutional investors. Comparatively, 49.4% of Semler Scientific shares are owned by institutional investors. 11.4% of InfuSystem shares are owned by company insiders. Comparatively, 16.4% of Semler Scientific shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Do analysts prefer INFU or SMLR?

InfuSystem presently has a consensus price target of $12.50, indicating a potential upside of 41.56%. Semler Scientific has a consensus price target of $81.75, indicating a potential upside of 126.27%. Given Semler Scientific's higher possible upside, analysts clearly believe Semler Scientific is more favorable than InfuSystem.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InfuSystem	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	3 Strong Buy rating(s)	4.00
Semler Scientific	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.25

Is INFU or SMLR more profitable?

Semler Scientific has a net margin of 86.20% compared to InfuSystem's net margin of 1.12%. Semler Scientific's return on equity of 43.84% beat InfuSystem's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InfuSystem	1.12%	2.78%	1.41%
Semler Scientific	86.20%	43.84%	32.88%

Summary

Semler Scientific beats InfuSystem on 9 of the 17 factors compared between the two stocks.